In the four months since he began serving as secretary of the Department of Health and Human Services, Robert F. Kennedy Jr.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Kennedy Jr. has made many public statements about vaccines that have cast doubt on their safety and on the objectivity of ...

In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...

The introduction of the heptavalent pneumococcal conjugate vaccine (PCV7) in the U.S. in 2000 was a welcome addition to our preventive armamentarium; however, questions remain regarding the degree ...

Family Physician, talks about the importance of adult vaccination, including the pneumococcal pneumonia vaccine.

Objectives To describe rates and variation in uptake of pneumococcal and measles, mumps and rubella (MMR) vaccines in children and associated change in vaccine-preventable diseases (VPDs) across the ...

The expanded approval of mResvia was supported by data from a phase 3 trial (ClinicalTrials.gov Identifier: NCT06067230) that evaluated the safety and immunogenicity of the vaccine in adults aged ...

US regulators approved Moderna Inc. ’s vaccine to prevent a common respiratory illness for more adults, a potential easing of the Trump administration’s opposition to mRNA technology. Moderna may sell ...

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on Thursday to include adults under the age of 60 at increased risk of the disease.

If the CDC approves ACIP's recommendations, that can lead to a vaccine becoming part of the official immunization schedule for children and adults. It also means insurance has to pay for it.